Ryan Miller

Statistics

Publications

Citations

104

H-Index

Active since

2021

Affiliations

Health Economics and Outcomes Research (United Kingdom)(Current)

Pfizer (United Kingdom)

Pfizer (Japan)

International University of Health and Welfare

Ryan Miller is an author at Health Economics and Outcomes Research (United Kingdom) specializing in chronic kidney disease management, renal pharmacotherapy, and outcomes research.

Publications per year

2021–2025

Publications

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease

Phil McEwan, Oliver Darlington, Ryan Miller et al. · Clinical Journal of the American Society of Nephrology · 2022 · 64 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes

Phil McEwan, Martin Bøg, Mads Faurby et al. · Journal of Medical Economics · 2025 · 18 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan

Tetsuya Matsumoto, Oliver Darlington, Ryan Miller et al. · Journal of health economics and outcomes research · 2021 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study

Tetsuya Matsumoto, Akira Yuasa, Ryan Miller et al. · PharmacoEconomics - Open · 2022 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

1–4 of 4